Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
JSON
Furer V, Rondaan C, Agmon-Levin N, van Assen S, Bijl M, Kapetanovic MC, de Thurah A, Mueller-Ladner U, Paran D, Schreiber K, Warnatz K, Wulffraat NM, Elkayam O
RMD Open 7 (1) e001594 [2021-02-00; online 2021-02-26]
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.
PubMed 33627440
DOI 10.1136/rmdopen-2021-001594
Crossref 10.1136/rmdopen-2021-001594
pii: rmdopen-2021-001594
pmc: PMC7907831